Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions.
In this work, we evaluated the chemical stability profiles of UC781 based solutions to identify excipients that stabilize the microbicidal agent UC781. When different antioxidants were added to UC781 in sulfobutylether-beta-cyclodextrin (SBE-beta-CD) solutions and subjected to a 50 degrees C stability study, it was observed that EDTA was a better stabilizing agent than sodium metabisulfite, glutathione or ascorbic acid. Some antioxidants accelerated the degradation of UC781, suggesting metal-catalyzed degradation of UC781. Furthermore, we observed substantial degradation of UC781 when stored in 1% Tween 80 and 1% DMSO solutions alone or in those with 10mM EDTA. On the other hand, improved stability of UC781 in the presence of 100 and 200mM of EDTA was observed in these solutions. The addition of both EDTA and citric acid in the stock solutions resulted in recovery of more than 60% of UC781 after 12 weeks. Generally, 10% SBE-beta-CD in the presence of EDTA and citric acid stabilized UC781 solutions: the amount of UC781 recovered approaching 95% after 12 weeks of storage at 40 degrees C. We also showed that the desulfuration reaction of the UC781 thioamide involves oxygen by running solution stability studies in deoxygenated media. Improved stability of UC781 in the present study indicates that the incorporation of EDTA, citric acid and SBE-beta-CD and the removal of oxygen in formulations of this drug will aid in increasing the stability of UC781 where solutions of the drug are required.
Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA.
Festo
F
Damian
Judit
J
Fabian
David R
DR
Friend
Patrick F
PF
Kiser
D000073738:2-Hydroxypropyl-beta-cyclodextrin; D000813:Anilides / Q000737:chemistry*; D000975:Antioxidants / Q000737:chemistry*; D000998:Antiviral Agents / Q000737:chemistry*; D001205:Ascorbic Acid / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D004121:Dimethyl Sulfoxide / Q000737:chemistry; D004339:Drug Compounding; D004355:Drug Stability; D004492:Edetic Acid / Q000737:chemistry; D005079:Excipients / Q000737:chemistry*; D005650:Fumarates / Q000737:chemistry; D005663:Furans / Q000737:chemistry*; D005978:Glutathione / Q000737:chemistry; D006358:Hot Temperature; D008956:Models, Chemical; D010084:Oxidation-Reduction; D011092:Polyethylene Glycols / Q000737:chemistry; D011136:Polysorbates / Q000737:chemistry; D012995:Solubility; D013447:Sulfites / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods; D013854:Thioamides; D013997:Time Factors; D014810:Vitamin E / Q000031:analogs & derivatives / Q000737:chemistry; D047392:beta-Cyclodextrins / Q000737:chemistry
D000813:Anilides; D000975:Antioxidants; D000998:Antiviral Agents; D005079:Excipients; D005650:Fumarates; D005663:Furans; D011136:Polysorbates; D013447:Sulfites; D013854:Thioamides; D047392:beta-Cyclodextrins; D014810:Vitamin E; D000073738:2-Hydroxypropyl-beta-cyclodextrin; C093196:SBE4-beta-cyclodextrin; D011092:Polyethylene Glycols; C005200:sodium metabisulfite; C032005:fumaric acid; D004492:Edetic Acid; D005978:Glutathione; C100668:UC-781; C014225:tocophersolan; D001205:Ascorbic Acid; D004121:Dimethyl Sulfoxide